A gene targeting strategy employing RNA-DNA oligonucleotides (RDO) has been developed to modify single-base mutations in chromosomal DNA. A primary limitation in the application of the RDO technology has been the lack of standardized systems to measure gene conversion in cells in a reproducible manner. A shuttle vector containing the E. coli beta-galactosidase gene with a G > A, inactivating, point mutation was constructed to measure the frequency of gene targeting by RDO. An RDO was shown to correct the point mutation and restore enzymatic activity in mammalian cells and in bacteria transformed with a Hirt extract DNA. An in vitro cell extract system capable of facilitating RDO-mediated correction was also established. These transfection and in vitro systems indicated that the shuttle vector system might be useful for comparing targeting frequency in different cell types and to investigate the mechanism of gene conversion by RDO. Using several different designs of RDO, it was determined that the number of RNA residues in the RNA portion of the chimera and the chemical modification of the hairpin loop were important for improving gene correction by RDO. In addition, it was determined that the replacement of a single mismatch in the DNA containing strand was important for inducing preferential mismatch repair. Two major proteins, a 130 kDA and a 100 kDa, also appear to be important in strand pairing of the target plasmid and its RDO homologue. The applicant proposes to further optimize RDO design and characterize the molecular intermediates involved in this process. The same system will also be used to investigate a rate-limiting step in gene conversion by comparing frequencies among cells containing specific defects in recombination and/or repair. Gene conversion will be measured at the biochemical, genetic, and molecular level utilizing the shuttle vector system already developed to understand the mechanisms involved in RDO-mediated correction and to optimize RDO design.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21GM061942-02
Application #
6387262
Study Section
Special Emphasis Panel (ZRG1-MEDB (01))
Program Officer
Wolfe, Paul B
Project Start
2000-08-01
Project End
2003-07-31
Budget Start
2001-08-01
Budget End
2003-07-31
Support Year
2
Fiscal Year
2001
Total Cost
$119,250
Indirect Cost
Name
Thomas Jefferson University
Department
Dermatology
Type
Schools of Medicine
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Igoucheva, Olga; Alexeev, Vitali; Yoon, Kyonggeun (2004) Mechanism of gene repair open for discussion. Oligonucleotides 14:311-21
Igoucheva, Olga; Alexeev, Vitali; Yoon, Kyonggeun (2004) Oligonucleotide-directed mutagenesis and targeted gene correction: a mechanistic point of view. Curr Mol Med 4:445-63
Yoon, Kyonggeun (2004) Montagna symposium on epidermal stem cells oligonucleotide-directed gene correction in epidermis. J Investig Dermatol Symp Proc 9:276-83
Igoucheva, Olga; Alexeev, Vitali; Pryce, Melissa et al. (2003) Transcription affects formation and processing of intermediates in oligonucleotide-mediated gene alteration. Nucleic Acids Res 31:2659-70
Pierce, E A; Liu, Q; Igoucheva, O et al. (2003) Oligonucleotide-directed single-base DNA alterations in mouse embryonic stem cells. Gene Ther 10:24-33
Igoucheva, Olga; Alexeev, Vitali; Yoon, Kyonggeun (2002) Nuclear extracts promote gene correction and strand pairing of oligonucleotides to the homologous plasmid. Antisense Nucleic Acid Drug Dev 12:235-46
Alexeev, V; Igoucheva, O; Yoon, K (2002) Simultaneous targeted alteration of the tyrosinase and c-kit genes by single-stranded oligonucleotides. Gene Ther 9:1667-75
Yang, S; Tutton, S; Pierce, E et al. (2001) Specific double-stranded RNA interference in undifferentiated mouse embryonic stem cells. Mol Cell Biol 21:7807-16